Antineoplastic drugs: clinical pharmacology and therapeutic use.
D000470:Alkaloids / Q000494:pharmacology; D000477:Alkylating Agents / Q000494:pharmacology; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001374:Azacitidine / Q000494:pharmacology; D001761:Bleomycin / Q000494:pharmacology; D002945:Cisplatin / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004347:Drug Interactions; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008727:Methotrexate / Q000494:pharmacology; D011034:Podophyllotoxin / Q000494:pharmacology
D000470:Alkaloids; D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003561:Cytarabine; D001761:Bleomycin; D003520:Cyclophosphamide; D011034:Podophyllotoxin; D001374:Azacitidine; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate